Combat Methamphetamine Epidemic Act of 2005
E67391
The Combat Methamphetamine Epidemic Act of 2005 is a U.S. federal law that restricts retail sales of pseudoephedrine and related precursors to curb the domestic production of methamphetamine.
Statements (46)
| Predicate | Object |
|---|---|
| instanceOf |
United States federal law
→
drug control legislation → |
| addresses |
diversion of precursor chemicals
→
domestic methamphetamine production → |
| aimsTo |
prevent diversion of legal cold medicines to illicit drug manufacturing
→
protect public health and safety → reduce methamphetamine-related crime → |
| appliesTo |
retail sales of ephedrine
→
retail sales of phenylpropanolamine → retail sales of pseudoephedrine → |
| chemicalTarget |
ephedrine
→
phenylpropanolamine → pseudoephedrine → |
| country |
United States
→
|
| enforcedBy |
Drug Enforcement Administration
→
state and local law enforcement agencies → |
| hasEffect |
increased regulatory burden on retailers of pseudoephedrine products
→
reduced availability of precursor chemicals for methamphetamine production → |
| imposes |
30-day sales limits on pseudoephedrine purchases
→
daily sales limits on pseudoephedrine purchases → quantity limits on mail-order sales of pseudoephedrine → quantity limits on mobile vendor sales of pseudoephedrine → |
| legalArea |
controlled substances regulation
→
pharmaceutical regulation → |
| partOf |
USA PATRIOT Improvement and Reauthorization Act of 2005
→
|
| purpose |
to curb domestic production of methamphetamine
→
to restrict access to methamphetamine precursors → |
| regulates |
over-the-counter cold medicines containing ephedrine
→
over-the-counter cold medicines containing phenylpropanolamine → over-the-counter cold medicines containing pseudoephedrine → |
| relatedTo |
Controlled Substances Act
→
United States methamphetamine control policies → |
| requires |
customer identification for purchase of pseudoephedrine products
→
customer signature in a logbook for pseudoephedrine purchases → placement of pseudoephedrine products behind the counter → recordkeeping of pseudoephedrine sales by retailers → |
| sectorAffected |
over-the-counter drug manufacturers
→
pharmacies → retail stores → |
| shortName |
CMEA
→
|
| subjectOf |
United States drug policy debates
→
public health discussions on methamphetamine abuse → |
| targets |
methamphetamine production in clandestine laboratories
→
|
| typeOfRestriction |
point-of-sale controls
→
purchase quantity limits → recordkeeping requirements → |
Referenced by (1)
| Subject (surface form when different) | Predicate |
|---|---|
|
Controlled Substances Act
→
|
amendedBy |